+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Contract Research Organization (CRO) - Global Strategic Business Report

  • PDF Icon

    Report

  • 89 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302569
The global market for Healthcare Contract Research Organization (CRO) was estimated at US$58.1 Billion in 2023 and is projected to reach US$83.6 Billion by 2030, growing at a CAGR of 5.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Healthcare Contract Research Organization (CRO) Market - Key Trends and Drivers Summarized

Why Is the Healthcare Contract Research Organization (CRO) Market Growing Rapidly?

The Healthcare Contract Research Organization (CRO) market has experienced rapid expansion due to the increasing complexity of drug development, growing R&D investments by pharmaceutical and biotechnology companies, and the rising trend of outsourcing clinical trials. As pharmaceutical companies aim to reduce costs and streamline their operations, outsourcing R&D and clinical trials to CROs has become a strategic move. CROs provide specialized services such as clinical research, data management, regulatory submissions, and clinical trial monitoring, all of which are integral to the successful development of new drugs. The rise of personalized medicine, coupled with increasing demand for niche therapeutic areas such as oncology and rare diseases, has further contributed to the growing reliance on CROs. Furthermore, the global nature of drug development has driven companies to seek expertise in navigating varied regulatory environments, positioning CROs as indispensable partners in clinical research.

What Emerging Technologies Are Shaping the Healthcare CRO Market?

Technology has transformed the CRO landscape, with advancements in artificial intelligence (AI), machine learning (ML), and big data analytics playing pivotal roles in optimizing clinical trials. These technologies enable more efficient trial design, faster patient recruitment, and real-time data analysis, significantly reducing the time to market for new drugs. The rise of decentralized clinical trials (DCTs), which allow for remote monitoring and data collection, has also gained traction, especially in the wake of the COVID-19 pandemic. This trend has allowed CROs to increase patient diversity and improve trial accessibility while lowering operational costs. In addition to these innovations, electronic health records (EHRs) and advanced data management systems have facilitated smoother data sharing and regulatory compliance, further strengthening the role of CROs in clinical trials.

How Are Market Segments Impacting the Healthcare CRO Industry?

The market can be broadly categorized into preclinical CRO services, clinical CRO services, and post-market CRO services, with clinical CRO services commanding the largest share due to the high demand for clinical trial outsourcing. In terms of application, oncology trials represent a significant segment, driven by increasing cancer prevalence and the need for innovative treatments. Other key therapeutic areas include neurology, cardiovascular diseases, and infectious diseases, all contributing to the rising demand for CRO services. End-use segments, including pharmaceutical and biotechnology companies, government organizations, and academic institutes, further fuel the growth of the CRO market, with large pharmaceutical firms being the primary consumers of CRO services.

What Factors Are Driving the Growth in the Healthcare CRO Market?

The growth in the healthcare CRO market is driven by several factors, including increasing R&D expenditures by pharmaceutical and biotech companies, growing demand for specialized clinical trial expertise, and the push for faster drug approvals. The shift toward personalized medicine and the need for targeted therapies are also expanding the scope of clinical trials, thus increasing the reliance on CROs for niche services. Regulatory complexities across different geographies require deep expertise, which CROs provide, thereby reducing time and costs for sponsors. Additionally, the trend toward decentralized and virtual clinical trials, supported by technological advancements, has further accelerated the adoption of CRO services. Rising investments in clinical research for rare diseases and the increasing number of biotech start-ups seeking cost-effective trial solutions are other key factors driving the growth of the CRO market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Clinical Type segment, which is expected to reach US$68.2 Billion by 2030 with a CAGR of a 5.4%. The Pre-Clinical Type segment is also set to grow at 5.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $15.8 Billion in 2023, and China, forecasted to grow at an impressive 5.0% CAGR to reach $13.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Axcent Advanced Analytics (A3), BIO Agile Therapeutics, Charles River Laboratories, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Questions Answered:

  • How is the Global Healthcare Contract Research Organization (CRO) Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Healthcare Contract Research Organization (CRO) Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Healthcare Contract Research Organization (CRO) Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Select Competitors (Total 33 Featured):

  • Axcent Advanced Analytics (A3)
  • BIO Agile Therapeutics
  • Charles River Laboratories
  • Covance, Inc.
  • Firma Clinical Research
  • GVK Biosciences Private Limited
  • ICON, plc.
  • IQVIA
  • Medidata Solutions, Inc.
  • Medpace Holdings
  • Paraxel International
  • Pharmaceutical Product Development, LLC (PPD)
  • Pharmaron
  • PPD
  • PRA Health Sciences
  • PSI CRO AG
  • SGS
  • Syneos Health

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Healthcare Contract Research Organization (CRO) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Surge in Outsourcing R&D Drives Growth of CRO Services
  • Increasing Complexity of Clinical Trials Spurs Demand for Specialized CROs
  • Growing Focus on Biopharmaceuticals Strengthens Business Case for Niche CROs
  • Accelerating Development of Personalized Medicine Expands Addressable Market Opportunity
  • Rising Adoption of Decentralized Clinical Trials Drives Market Growth
  • Integration of AI and Machine Learning in Drug Development Spurs Growth
  • Growing Investments in Oncology Research Generates Demand for Oncology-focused CROs
  • Emerging Markets Propel Outsourcing Trends and Regional CRO Expansion
  • Cost-Pressures in Pharmaceutical Industry Sustain Growth of CRO Services
  • Technological Innovations in Data Analytics Strengthen CRO Value Proposition
  • Rising Focus on Real-World Evidence Generates Demand for Post-Market CRO Services
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Clinical Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Quality Management / Assurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Project Management / Clinical Supply Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Regulatory / Medical Affairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 28: World Healthcare Contract Research Organization (CRO) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: USA Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: USA 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: USA Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: USA 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Canada 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Canada 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
JAPAN
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 41: Japan Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Japan 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Japan 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
CHINA
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 47: China Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: China Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: China 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: China Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: China 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
EUROPE
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 53: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
FRANCE
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 62: France Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: France Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: France 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 65: France Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: France Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: France 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
GERMANY
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 68: Germany Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Germany 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 71: Germany Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Germany 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
ITALY
  • Table 74: Italy Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: Italy 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 77: Italy Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: Italy 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 80: UK Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: UK Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: UK 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 83: UK Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: UK Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: UK 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Rest of Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Asia-Pacific 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Axcent Advanced Analytics (A3)
  • BIO Agile Therapeutics
  • Charles River Laboratories
  • Covance, Inc.
  • Firma Clinical Research
  • GVK Biosciences Private Limited
  • ICON, plc.
  • IQVIA
  • Medidata Solutions, Inc.
  • Medpace Holdings
  • Paraxel International
  • Pharmaceutical Product Development, LLC (PPD)
  • Pharmaron
  • PPD
  • PRA Health Sciences
  • PSI CRO AG
  • SGS
  • Syneos Health

Table Information